Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03244176
Title Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study (AvR-CHOP)
Acronym AvR-CHOP
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Austin Health
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.